PomDoctor met Nasdaq’s $1 minimum share-price rule, and Nasdaq canceled its scheduled hearing. This removes an immediate listing concern, though the company had spent 30 business days below the threshold.
Meeting Nasdaq’s rule removes the immediate problem that had put a hearing on the calendar. The earlier 30 business days below $1 shows this was a real issue, but the company has since met the rule.
Follow PomDoctor Limited (POM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for POM